Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome
Clinical trial NCT04401748 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04401748
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-10
- Primary completion
- 2027-07-01
- Enrollment
- 531
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.